DYNE THERAPEUTICS INC (DYN) Stock Cash Flow
NASDAQ:DYN - Nasdaq - US26818M1080 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -412.89M | -317.42M | -235.94M | -168.10M | -149.29M | |||
| Depreciation Amortization | 1.89M | 1.67M | 1.67M | 1.68M | 1.09M | |||
| Change In Working Capital | 11.13M | -19.49M | 26.31M | -5.38M | 9.26M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 40.30M | 42.87M | 19.80M | 18.15M | 19.38M | |||
| OPERATING CASH FLOW | -359.56M | -292.37M | -188.16M | -153.65M | -119.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.37M | -2.38M | -729.00K | -3.07M | -3.62M | |||
| Other Investing Activity | -24.81M | -201.70M | 84.04M | 90.27M | -134.27M | |||
| INVESTING CASH FLOW | -27.18M | -204.08M | 83.31M | 87.20M | -137.89M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 164.86M | 809.89M | 54.32M | 37.39M | 157.82M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 263.66M | 809.89M | 54.32M | 37.39M | 157.82M | |||
| CHANGE IN CASH | -123.08M | 313.45M | -50.52M | -29.06M | -99.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -359.56M | -292.37M | -188.16M | -153.65M | -119.56M | |||
| Capital Expenditure | -2.37M | -2.38M | -729.00K | -3.07M | -3.62M | |||
| FREE CASH FLOW | -361.93M | -294.75M | -188.89M | -156.72M | -123.18M | |||
All data in USD